Literature DB >> 12379876

Epidemiology of tobacco use in the United States.

Gary A Giovino1.   

Abstract

Efforts to understand trends in and patterns of lung cancer are well served by studies of trends in and patterns of tobacco use. In the United States, the manufactured cigarette emerged as the tobacco product of choice shortly after the turn of the twentieth century. Lung cancer emerged after years of inhalation of cigarette smoke, first among men and then among women. The massive public health education campaign that began after scientists recognized the dangers of cigarette smoking has contributed to large reductions in cigarette use and subsequent smoking-attributable morbidity and mortality. Since 1965, the prevalence of cigarette smoking among US adults has declined by almost half, with positive trends observed among persons in almost all sociodemographic groups and efforts to reduce disparities recognized as an important goal in public health. An epidemiologic approach to understanding and controlling patterns of tobacco use is proposed. The model focuses on the agent (tobacco products), host (consumer or potential consumer), vector (tobacco companies and other users), and environment (with influences from families, social sources, culture, history, politics, law, and media). Accelerating progress in reducing tobacco use will accelerate reductions in tobacco-attributable morbidity and mortality.

Entities:  

Mesh:

Year:  2002        PMID: 12379876     DOI: 10.1038/sj.onc.1205808

Source DB:  PubMed          Journal:  Oncogene        ISSN: 0950-9232            Impact factor:   9.867


  84 in total

1.  A randomized, controlled trial of NRT-aided gradual vs. abrupt cessation in smokers actively trying to quit.

Authors:  John R Hughes; Laura J Solomon; Amy E Livingston; Peter W Callas; Erica N Peters
Journal:  Drug Alcohol Depend       Date:  2010-05-26       Impact factor: 4.492

Review 2.  Regulatory strategies to reduce tobacco addiction in youth.

Authors:  J E Henningfield; E T Moolchan; M Zeller
Journal:  Tob Control       Date:  2003-06       Impact factor: 7.552

3.  Cancer prevention health services research: an emerging field.

Authors:  Hui Zhao; Jennifer H Tektiridis; Ning Zhang; Robert M Chamberlain
Journal:  J Cancer Educ       Date:  2012-05       Impact factor: 2.037

4.  Psychological distress and smoking behavior: the nature of the relation differs by race/ethnicity.

Authors:  Marc T Kiviniemi; Heather Orom; Gary A Giovino
Journal:  Nicotine Tob Res       Date:  2010-12-15       Impact factor: 4.244

5.  Illicit drug use in heavy smokers with and without schizophrenia.

Authors:  Kristen M Mackowick; Stephen J Heishman; Heidi J Wehring; Fang Liu; Robert P McMahon; Deanna L Kelly
Journal:  Schizophr Res       Date:  2012-05-14       Impact factor: 4.939

Review 6.  The feasibility of smoking reduction: an update.

Authors:  John R Hughes; Matthew J Carpenter
Journal:  Addiction       Date:  2005-08       Impact factor: 6.526

Review 7.  Framing tobacco control efforts within an ethical context.

Authors:  B J Fox
Journal:  Tob Control       Date:  2005-08       Impact factor: 7.552

8.  An Exome-Wide Association Study Identifies New Susceptibility Loci for Age of Smoking Initiation in African- and European-American Populations.

Authors:  Keran Jiang; Zhongli Yang; Wenyan Cui; Kunkai Su; Jennie Z Ma; Thomas J Payne; Ming D Li
Journal:  Nicotine Tob Res       Date:  2019-05-21       Impact factor: 4.244

Review 9.  Surveillance methods for identifying, characterizing, and monitoring tobacco products: potential reduced exposure products as an example.

Authors:  Richard J O'Connor; K Michael Cummings; Vaughan W Rees; Gregory N Connolly; Kaila J Norton; David Sweanor; Mark Parascandola; Dorothy K Hatsukami; Peter G Shields
Journal:  Cancer Epidemiol Biomarkers Prev       Date:  2009-12       Impact factor: 4.254

10.  Childhood passive smoke exposure is associated with adult head and neck cancer.

Authors:  Jesse D Troy; Jennifer R Grandis; Ada O Youk; Brenda Diergaarde; Marjorie Romkes; Joel L Weissfeld
Journal:  Cancer Epidemiol       Date:  2013-04-22       Impact factor: 2.984

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.